Impaired Nitric Oxide–Mediated Renal Vasodilation in Rats With Experimental Heart Failure
- 18 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (10) , 3655-3664
- https://doi.org/10.1161/01.CIR.96.10.3655
Abstract
Background Congestive heart failure (CHF) is associated with a decrease in renal perfusion. Because endothelium-derived NO is important in the regulation of renal blood flow (RBF), we tested the hypothesis that an impairment in the NO system may contribute to the decrease in RBF in rats with experimental CHF. Methods and Results Studies were performed in rats with experimental high-output CHF induced by aortocaval (AV) fistula and sham-operated controls. In controls, incremental doses of acetylcholine (ACh, 1 to 100 μg · kg −1 · min −1 ) increased RBF and caused a dose-related decrease in renal vascular resistance (RVR). However, the increase in RBF and decrease in RVR were markedly attenuated in rats with CHF. Likewise, the effects of ACh on urinary sodium and cGMP excretion were also diminished in CHF rats, as was the renal vasodilatory effect of the NO donor S -nitroso- N -acetylpenicillamine (SNAP). These attenuated responses to endothelium-dependent and -independent renal vasodilators in CHF rats occurred despite a normal baseline and stimulated NO 2 +NO 3 excretion and normal expression of renal endothelial NO synthase (eNOS), as determined by eNOS mRNA levels and immunoreactive protein. Infusion of the NO precursor l -arginine did not affect baseline RBF or the response to ACh in rats with CHF. However, administration of the nonpeptide angiotensin II receptor antagonist A81988 before ACh completely restored the renal vasodilatory response to ACh in CHF rats. Conclusions This study demonstrates that despite a significant attenuation in the NO-related renal vasodilatory responses, the integrity of the renal NO system is preserved in rats with chronic AV fistula. This impairment in NO-mediated renal vasodilation in experimental CHF appears to be related to increased activity of the renin-angiotensin system and may contribute further to the decrease in renal perfusion seen in CHF.Keywords
This publication has 20 references indexed in Scilit:
- Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?The Lancet, 1994
- Temporal evolution of endothelial dysfunction in a rat model of chronic heart failureJournal of the American College of Cardiology, 1993
- Nitric oxide modulates vascular tone in preglomerular arterioles.Hypertension, 1992
- Endothelial function in chronic congestive heart failureThe American Journal of Cardiology, 1992
- Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats.Journal of Clinical Investigation, 1992
- Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells.Journal of Clinical Investigation, 1992
- Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.Journal of Clinical Investigation, 1991
- Effects of atrial natriuretic factor in rats with experimental high-output heart failureKidney International, 1988
- Renal and circulatory mechanisms in congestive heart failureKidney International, 1987
- Mechanism of sodium and water retention in rats with experimental heart failureKidney International, 1973